A Multicenter, Randomized, Double-Blind, Placebo-Controlled 'Factorial' Design Study to Evaluate the Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Combination Tablet in Patients With Primary Hypercholesterolemia.
Latest Information Update: 05 May 2022
At a glance
- Drugs Ezetimibe/simvastatin (Primary) ; Simvastatin
- Indications Hypercholesterolaemia
- Focus Registrational; Therapeutic Use
- Sponsors Organon
- 30 Aug 2005 New trial record.